Cardiovascular response to exogenous serotonin in healthy calves

American Journal of Veterinary Research

Volumn 57, Issue 5, 1996, Pages 731-738

  Linden, Annick S ^a   Desmecht, Daniel J M ^a   Amory, Hélène ^a   Beduin, Jean Marie ^a   Lekeux, Pierre M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CATTLE; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; DOSE RESPONSE; DRUG EFFECT; HEART OUTPUT; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TACHYCARDIA; TIME; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; BRADYCARDIA; CARDIAC OUTPUT; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CATTLE; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; TACHYCARDIA; TIME FACTORS; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030143953     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Rapport MM, Green AA, Page IH Serum vasoconstrictor serotonin. IV. Isolation and characterisation. J Biol Chem 1948.176. 1243
2. Cohen ML, Fuller RW, Wiley KS. Evidence for 5-HT, receptors mediating contraction in vascular smooth muscle J Pharmacol Exp Then 1981;218 421-425.
3. Purdy RE, Murray, DL, Stupecky GL Receptors for 5-hydroxy-tryptamine in rabbit blood vessels, activation of alpha adienoceptors in rabbit thoracic aorta J Pharmacol Exp Ther 1987,240: 535-541
4. Van Nueten JM, Janssen PAJ, De Ridder W, et al Interaction between 3-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit: effect of ketanserin R41468 Eur J Pharmacol 1982,77.281-287
5. Humphrey PPA, Femuk W, Watts AD Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system. Fed Proc 1983;42-218-222.
6. Mylecharanc EJ, Phillips CA. Mechanisms of 5-hydroxytryptamine induced vasodilatation In Fozard JR, ed. The peripheral actions of 5-hydroxytryptmine. Oxford, England. Oxford University Press, 1989;147-181.
7. Göthert M. Serotomn receptors in the circulatory system. Prog Pharmacol 1986,6.155-172
8. Kuhn DM, Wolf WA, Lovenberg W. Review of the role of the central serotonergic neuronal system in blood pressure regulation Hypertension 1980,2:243-255.
9. McQueen DS, Mir AK. 5-Hydroxytryptamine and cardiopulmonary and carotid body reflex mechanisms In: Fozard JR. ed The peripheral actions of 5-hydroxytryptamine Oxford, England; Oxford University Press, 1989;301-326
10. Schneider JA, Yonkman FF. Species differences in the respiratory and cardiovascular response to serotonin 5-hydroxytryptamine. J Pharmacol Exp Ther 1954;111:84-98.
11. Bolt GR, Saxena PR Cardiovascular profile and hypertensive mechanism of ketanserin in conscious renal hypertensive rabbits. Hypotension 1985,7:499-506
12. Saxena PR, Verdouw PD. Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous blood flow. J Physiol 1982,332:501-520.
13. Fozard JR. Neuronal 5-HT receptors in the periphery Neuropharmacology 1984;23:1473-1486
14. Richardson BP, Engel G, Donatsch P, et al. Identification of M-receptor subtypes and their specific blockade by a new class of drugs Nature 1985;316:126-131.
15. Saxena PR Nature of the 5-hydroxytryptamine receptors in mammalian heart. Prog Pharmacol 1986;6:173-185
16. Wilson H, Coffman WJ, Cohen ML 5-Hydroxytryptamine 3 receptors mediate tachycardia in conscious instrumented dogs. J Pharmacol Exp Ther 1990,252:683-688.
17. 1-like receptors Naunyn Schmiedebergs Arch Pharmacol 1985;330.121-129
18. Docherty JR. Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat. Naunyn Schmiedebergs Arch Pharmacol 1988,337.1-8.
19. Bom AH, Duncker DJ, Saxena PR, et al 5-Hydroxytiyptamine-induced tachycardia in the pig possible involvement of a new type of 5-hydroxytryptamine receptor. Br J Pharmacol 1988;93:663-671.
20. Greenlees KJ, Tucker A, Robertshaw D, et al Pulmonary vascular responsiveness in cold-exposed calves. Can J Physiol Pharmacol 1985;63.131-135.
21. Desmecht DJ-M, Linden AS, Rollin FA, et al. Effect of intravenous and aerosol administration of 5-hydroxytryptamine on pulmonary function values in healthy calves. Am J Vet Res 1992,53 315-320
22. Bergofsky EH Mechanisms underlying vasomotor regulation of regional pulmonary blood flow in normal and disease states. Am J Med 1974;57:378-394
23. Seldinger SI Catheter replacement of the needle in percutaneous arteriography. Acta Radiol 1953,39 368-376
24. Darovic GO Hemodynamic monitoring. In Kay D, ed. Invasive and noninvosive clinical application. Philadelphia. WB Saunders Co, 1987.
25. Amary H, Linden AS, Desmecht DJ-M, et al. Validation of the thermodilution technique for the estimation of the cardiac output in the unsedated calf Zentralbl Veterinarmed [A] 1991,38.409-417.
26. Olsson B, Pool J, Vandermooten P, et al. Validity and reproducibility of determination of cardiac output by thermodilution in man. Cardiology 1970;55:136-148
27. Amory H, Desmecht DJ-M, Linden AS, et al Growth-induced haemodynamic changes in the healthy Friesian calf. Vet Rec 1993,132:426-434
28. Winer BJ Single-factor experiments having repeated measures on the same elements. In Statistical principles in experimental design. 2nd ed New York McGraw-Hill Book Co, 1971:196-201.
29. Searle SR. Linear models New York: John Wiley & Sons, 1971.
30. SAS user's guide: statistics, version 6 ed Cary, NC: SAS Institute Inc, 1990
31. Gross DR, Dodd KT, William JD, et al Adverse cardiovascular effects of oxytetracycline preparations and vehicles in intact awake calves Am J Vet Res 1981;42.1371-1377.
32. Manohar M, Parks CM, Busch MA Regional myocardial blood flow and coronary vascular reserve in unanesthetized young calves exposed to a simulated altitude of 3500 m for 8-10 weeks. Circ Res 1982;50:714-726
33. Huntington GB, Eisemnan JH, Whitt JM. Portal blood flow in beefsteers: comparison of techniques and relation to hepatic blood flow, cardiac output and oxygen uptake. J Anim Sci 1990,68.1666-1673.
34. Wagner AE, Muir WW, Grospitch BJ. Cardiopulmonary effects of position in consious cattle. Am J Vet Res 1990,51:7-10.
35. Kuipers JRG, Sidi D, Heymann MA. Comparison of methods of measuring cardiac output in newborn lambs. Pediatr Res 1982 16:594-598.
36. Colebatch, HJH, Olsen CR, Nadel JA Effect of histamine, serotonin, and acethylcholine on the peripheral airways. J Appl Physiol 1966;21 217-226.
37. Buckner CK, Dea D, Liberati N, et al. A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig. J Pharmacol Exp Ther 1991, 237:26-34.
38. Aitken MM, Sanford J Effects of histamine, 5-hydroxytryptamine and bradykinin on cattle and their modification by antagonists by vagotomy J Comp Pathol 1972;82:257-266.
39. Dhasmana KM, De Boer HJ, Banerjee AK, et al. Analysis of the tachycardiac response to 5-hydroxytryptamine in the spinal guinea-pig. Eur J Pharmacol 1988;145.67-73.
40. Krayer O. The history of the Bezold-Jarisch effect. Naunyn Schmiedebergs Arch Pharmacol 1961;240:361-368
41. Paintal AS. Vagal sensory receptors and their reflex effects Physiol Rev 1973,53 159-227.
42. Fozard JR. MDL 72222. a potent and highly selective antagonist at neuronal 5-hydroxytrypiamine receptors Naunyn Schmiedebergs Arch Pharmacol 1984,326.36-44.
43. Coleridge HM, Coleridge JCG. Reflexes evoked from tracheobronchial tree and lungs In: Fishman AP, Cherniak NS, Widdicombe JG, et al, eds Handbook of physiology The respiratory system. Vol 2 Bethesda, Md American Physiological Society, 1986,395-429.
44. Fastier FN, McDowall MA, Wall H. Pharmacological properties of phenyldiguanide and other amidine derivatives in relation to those of 5-hydroxytryptamine Br J Pharmacol 1959;14:527-535.
45. Paintal AS. Mechanism of stimulation of type J pulmonary receptors J Physiol Lond 1969;203 511-532
46. Kay IS. Armstrong DJ MDL72222, a selective 5-HT, receptor antagonist prevents stimulation of intrapulmonary C fibres by pulmonay embolization in anaesthetized rabbits. Exp Physiol 1991, 76.213-218
47. Dalton DW. The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat J Auton Pharmacol 1986;6.67-75
48. Bogle RG, Pires JGP, Ramage AG. Evidence that central 5-HTIA-receptors play a role in the von Bezold-Harisch reflex in the rat. Br J Pharamcol 1990,100:757-760.
49. 4 receptor Br J Pharmacol 1990;100:665-667.
50. Thomas DP, Vane JR. 5-Hydroxytryptamine in the circulation of the dog. Nature 1967,216 335-338
51. Buccino RA, Covell JW, Sonnenblick EH, et al. Effects of serotonin on the contractile state of the myocardium Am J Physiol 1967;213-483-486
52. Alexander F, Eyre P, Head KW, et al. Effects of histamine and 5-hydroxytryptamine on sheep. J Comp Pathol 1967;77:1-12.
53. 2 serotonergic receptors J Pharmacol Exp Ther 1981,218.217-230.
54. Feniuk W, Humphrey PPA, Perren MJ, et al. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit isolated aorta and dog saphenous vein Evidence for different receptor types obtained by the use of selective agonists and antagonists, Br J Pharmacol 1985;86:697-704.
55. 2 receptors in pulmonary and coronary arteries of calf. Naunyn Schmiedebergs Arch Pharmacol 1984, 326:334-339.
56. Vanhoutte PM, Cohen RA, Van Nueten JM. Serotonin and arterial vessels J Cardiovasc Pharmacol 1984,6:5421-5428
57. Van Nueten JM, Vanhoutte PM. Serotonin and vascular function. Clin Anaesthesiol 1984;1:363-381
58. 2 receptor blockade to study serotonin-induced pathology Trends Pharmacol Sci Rev 1983;May:198-206
59. 2 type, mediating contraction of isolated rabbit basilar artery. Br J Pharmacol 1986;87:3-4.
60. 2+-entry blockade and serotonergic antagonism in contractions of hypoxic isolated canine coronary arteries. Arch Int Pharmacodyn Ther 1983;265:172-176.
61. Lindblad LE, Shepherd JT, Vanhoutte PM. Cooling augments platelet-induced contraction of peripheral arteries of the dog. Proc Soc Exp Biol Med 1984;176:119-122.
62. Mullane KM, Bradley G, Moncada S. The interactions of platelet-derived mediators on isolated canine coronary arteries. Eur J Pharmacol 1982;84:115-118.
63. Black JL, French RJ, Mylecharane EJ. Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries. Br J Pharmacol 1981;74: 619-626.
64. Luscher TF, Vanhoutte PM. Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rats. Hypertension 1986;8(Suppl 2):55-60.
65. De Clerck FF, Herman AG. 5-Hydroxytryptamine and platelet aggregation. Fed Proc 1983,42:228-232.
66. Eyre P. Atypical tryptamine receptors in sheep pulmonary veins. Br J Pharmacol 1975;55:329-333
67. Feniuk W, Humphrey PPA, Watts AD. 5-Hydroxytraptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol 1983,96.71-78.
68. Cohen RA, Shepherd JT, Vanhoutte PM. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 1983;245:H1077-H1080.
69. Kubo T, Su C Effects of serotonin and some other nuerohumoral agents on adrenergic neurotransmission in spontaneously hypertensive rat vasculature Clin Exp Hypertens 1983;5:1501-1510.
70. Hofman WF, Jackson WF, el-Kashef H, et al. Modulation of vascular reactivity to serotonin in the dog lung. J Appl Physiol 1991;71:217-222.
71. De Clerck FF, Vanhoutte M. In. De Clerck F, Vanhoutte PM, eds. 5-Hydroxytryptamine in peripheral reactions. New York: Raven Press, 1982
72. Cutaia M, Porcellin RJ. Pulmonary vascular reactivity after repetitive exposure to selected biogenic amines. J Appl Physiol 1983, 55.1868-1876.
73. Le Roux MGJ, Syce JA. The effect of ketanserin on serotonin-induced vascular responses in the isolated perfused rat lung. Ear J Pharmacol 1989;169:269-273.
74. Eyre P. Pharmacology of bovine pulmonary vein anaphylaxis in vitro Br J Pharmacol 1971;43:302-311.